English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Csl Behring
+
Technology/Innovation
Carol Ostrow
| Dec 16, 2017
CSL partners with Vitaeris for organ transplant therapy
+
Community
Carol Ostrow
| Sep 29, 2017
CSL Behring pledges $4.92 million for Penn State biotechnology center
Erianne Leatherman
| Apr 18, 2017
CSL Behring honors World Hemophilia Day with medications donation
Erianne Leatherman
| Apr 14, 2017
CSL Behring awards grants to four groups to boost support for patients with rare diseases
Erianne Leatherman
| Apr 12, 2017
CSL Behring to sponsor Jeffrey Modell North African Network for primary immunodeficiency
+
Regulatory
Jeff Gantt
| Dec 18, 2016
Afstyla approved by Health Canada
+
Community
Amanda Rupp
| Jun 22, 2016
CSL Behring honors 2016 HAE Day with events
+
Technology/Innovation
Amanda Rupp
| Jun 1, 2016
Afstyla gains FDA approval as hemophilia A treatment
Trending
+
Pharmaceuticals
Patient Daily
| Aug 4, 2026
Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+
Pharmaceuticals
Patient Daily
| Aug 6, 2026
FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+
Regulatory
M. R. Armstrong
| Aug 4, 2026
Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+
Pharmaceuticals
Patient Daily
| Aug 5, 2026
Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes
